NON-IMMUNOGENIC RECOMBINANT STAPHYLOKINASE VERSUS ALTEPLASE FOR PATIENTS WITH ACUTE ISCHAEMIC STROKE 4·5 H AFTER SYMPTOM ONSET IN RUSSIA (FRIDA): A RANDOMISED, OPEN LABEL, MULTICENTRE, PARALLEL-GROUP, NON-INFERIORITY TRIAL СтатьяGusev E.I., Martynov M.Y., Nikonov A.A., Shamalov N.A., Semenov M.P., Gerasimets E.A., Yarovaya E.B., Semenov A.M., Archakov A.I., Markin S.S., Aksentiev S.B., Yunevich D.S., Alasheev A.M., Androfagina O.V., Bobkov V.V., Choroshavina K.V., Chefranova J.Y., Lykov Y.A., Chuprina S.E., Vorobev A.A. ...The Lancet Neurology. Том 20. 2021. С. 721-728
